You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-37. Amphetamines and ecstasy clients entering drug treatment, 2007 or most recent year available [see all tables in this series...]

Part (v) Inpatient clients by secondary drug and primary drug

Secondary drug	Amphetamines	MDMA and other derivatives
Secondary drug
Opioids	523	15
Cocaine	183	32
Cannabis	1340	85
Alcohol	545	17
Stimulants (other than cocaine)	197	26
Hypnotics and sedatives	470	20
Hallucinogens	97	5
Volatile	41	6
Other substances	25	6
Total number of citations	3421	212

Notes:

Clients may report one primary drug, but more than one secondary drug

Countries providing data are: BE, BG, CZ, DK, IE, EL, FR, CY, LV, LU, AT, RO, SK, FI, SE, UK

The number of treatment clients in each country is listed in Table TDI-7.

See also 'General notes for interpreting data’ on the Explanatory notes and help page.

Sources:

Reitox national reports 2008 — Table TDI by centre type.

Download this data in Excel (.xls) format

(see the help page for information about formats etc.)